Triple gastrointestinal prophylactic therapy following high-power short-duration posterior left atrial wall ablation

CANDEMİR B., Baskovski E., Mammadov M., ESENBOĞA K., Altin T.

INDIAN HEART JOURNAL, cilt.72, sa.4, ss.306-308, 2020 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 72 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.ihj.2020.06.007
  • Dergi Adı: INDIAN HEART JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.306-308
  • Anahtar Kelimeler: Atrial fibrillation, Catheter ablation, Complication, Proton-pump inhibitor, PULMONARY VEIN ISOLATION, CATHETER ABLATION, ATRIOESOPHAGEAL FISTULA, FIBRILLATION, LESIONS, SAFETY, PREVENTION, COLCHICINE, MECHANISMS, EFFICACY
  • Ankara Üniversitesi Adresli: Evet

Özet

The purpose of this study is to investigate incidence of gastrointestinal symptoms and complications in patients who underwent high-power short-duration (HPSD), posterior left atrial wall isolation during atrial fibrillation ablation and thereafter have received gastrointestinal prophylactic regimen consisting of sucralfate, proton-pump inhibitor and colchicine. Patients were followed and assessed at baseline, up until 6th month following the procedures.Among 115 patients who were included, 5 patients (4.3%) reported gastrointestinal symptoms at follow-up. No complications were diagnosed during the followup. In conclusion, the HPSD along with prophylactic regimen has been associated with low incidence of gastrointestinal adverse events. (C) 2020 Cardiological Society of India. Published by Elsevier B.V.